Neural correlates of free T3 alteration after catecholamine depletion in subjects with remitted major depressive disorder and in controls.

Homan, Philipp; Drevets, Wayne C; Hasler, Gregor (2014). Neural correlates of free T3 alteration after catecholamine depletion in subjects with remitted major depressive disorder and in controls. Psychopharmacology, 231(2), pp. 409-17. Springer 10.1007/s00213-013-3250-2

[img]
Preview
Text
FT3_AMPT_PET_0.309_publ_R1.pdf - Submitted Version
Available under License Publisher holds Copyright.

Download (216kB) | Preview
[img]
Preview
Text
art%3A10.1007%2Fs00213-013-3250-2.pdf_auth66=1398860106_1bce89f2baa431dea5ea65b6ea538a0a&ext=.pdf - Published Version
Available under License Publisher holds Copyright.

Download (362kB) | Preview

RATIONALE:

Thyroid hormones and their interactions with catecholamines play a potentially important role in alterations of mood and cognition.

OBJECTIVES:

This study aimed to examine the neurobiological effects of catecholamine depletion on thyroid hormones by measuring endocrine and cerebral metabolic function in unmedicated subjects with remitted major depressive disorder (RMDD) and in healthy controls.

METHODS:

This was a randomized, placebo-controlled, and double-blind crossover trial that included 15 unmedicated RMDD subjects and 13 healthy control subjects. The participants underwent two 3-day-long sessions at 1-week intervals; each participant was randomly administered oral α-methyl-para-tyrosine in one session (catecholamine depletion) and an identical capsule containing hydrous lactose (sham depletion) in the other session prior to a [(18)F]-fluorodeoxyglucose positron emission tomography scan.

RESULTS:

Serum concentrations of free T3 (FT3), free T4 (FT4), and TSH were obtained and assessed with respect to their relationship to regional cerebral glucose metabolism. Both serum FT3 (P = 0.002) and FT4 (P = 0.0009) levels were less suppressed after catecholamine depletion compared with placebo treatment in the entire study sample. There was a positive association between both FT3 (P = 0.0005) and FT4 (P = 0.002) and depressive symptoms measured using the Montgomery-Åsberg Depression Rating Scale. The relative elevation in FT3 level was correlated with a decrease in regional glucose metabolism in the right dorsolateral prefrontal cortex (rDLPFC; P < 0.05, corrected).

CONCLUSIONS:

This study provided evidence of an association between a thyroid-catecholamine interaction and mood regulation in the rDLPFC.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > University Psychiatric Services > University Hospital of Psychiatry and Psychotherapy > Healthcare Research
04 Faculty of Medicine > University Psychiatric Services > University Hospital of Psychiatry and Psychotherapy > Management

UniBE Contributor:

Homan, Philipp, Hasler, Gregor

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0033-3158

Publisher:

Springer

Language:

English

Submitter:

Daniela Zurkinden

Date Deposited:

06 Aug 2014 08:52

Last Modified:

05 Dec 2022 14:33

Publisher DOI:

10.1007/s00213-013-3250-2

PubMed ID:

23954912

Uncontrolled Keywords:

Triiodothyronine, PET, Thyroid, Depression, Catecholamines, Dorsolateral prefrontal cortex

BORIS DOI:

10.7892/boris.50003

URI:

https://boris.unibe.ch/id/eprint/50003

Actions (login required)

Edit item Edit item
Provide Feedback